Novozymes A/S (NVZMY) Expected to Announce Quarterly Earnings on Thursday

Novozymes A/S (OTCMKTS:NVZMY) is projected to issue its resultson Thursday, May 14th. Analysts expect the company to announce earnings of $0.8160 per share and revenue of $1.3230 billion for the quarter.

Novozymes A/S (OTCMKTS:NVZMY) last released its quarterly earnings data on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.31). The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Novozymes A/S had a return on equity of 6.57% and a net margin of 14.22%. On average, analysts expect Novozymes A/S to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Novozymes A/S Stock Performance

OTCMKTS NVZMY opened at $61.27 on Thursday. The stock’s fifty day moving average is $58.31 and its two-hundred day moving average is $61.13. The firm has a market capitalization of $25.40 billion, a P/E ratio of 41.40, a price-to-earnings-growth ratio of 1.17 and a beta of 0.98. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.44 and a current ratio of 0.72. Novozymes A/S has a fifty-two week low of $49.90 and a fifty-two week high of $75.99.

Analysts Set New Price Targets

NVZMY has been the topic of a number of recent research reports. Rothschild & Co Redburn raised Novozymes A/S to a “strong-buy” rating in a research note on Friday, March 27th. Zacks Research lowered Novozymes A/S from a “hold” rating to a “strong sell” rating in a research note on Monday. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).